{"name":"Pinteon Therapeutics, Inc","slug":"pinteon-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPVy05alhRWmZmS3o4OWhZSHZYbncxdi1GU296QXBzSmpDal8wTmZtdHlRSDdLeXhRWnRzUGktWWpCVHNXa29NSktVTTRreFBaUHJtZUUwWG5ONHZyTGs5RUkwaDhjQkF6dWtfQXMyR29rQnpaNnVuLVdybi1tQ1BESEFLUkNXT080bDVkZg?oc=5","date":"2024-10-14","type":"trial","source":"Yahoo Finance","summary":"Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - Yahoo Finance","headline":"Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOd3EyTXR0Z25scDRrUWhYdjhmY0Z3MjNLUGtiVzZUa19VVnZ1YjFVNnpZaTg0U0I5SkNrcVRaaHV4Zk9qQ3J5c0lzVmwwdUh3bHdSUl9sY2VicEJadHpyU0dTaUlrdGxGRTZJT1BoMHg4QzlFbXZHaWpqSVB6RmUzUlJ3?oc=5","date":"2022-07-05","type":"trial","source":"Clinical Trials Arena","summary":"Pipeline Moves: Nektar terminates Phase I/II cancer trial, further study shot in seven indications drop - Clinical Trials Arena","headline":"Pipeline Moves: Nektar terminates Phase I/II cancer trial, further study shot in seven indications drop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQOGtTV21Ec25WMUlpMHU1cGtoZ0puWkw2ajB1MVJ2TTRmYkd2eTZsZGU4Y2M4RHlLeHlIN2lWNXR2ZUZ3NlZMeUlWLUNCUWtIX2RsVU5fcWxyMHRTdEdoVWo1TUQtOXdyV2tZaEdYVkFWNlIxNU9CSFR5bS1ITy00dzhIaGMwNVRpT0VrNGJpZERoZGUwQmhGYjU0dEtkUGJnMmJLajMwYTA1SUxoMU0zT0hKZ08teDlObGJydENNY1ZrZmJ1a2lqVm9Fc1lKcm9OVWVzSVlZeG04M1FKNURPSnNzb0ZqWThLWUJJWWhOcmhTNDJUN2tHTThYNG5LaGFJdnRWRzVqcW1Sa2lDd2VudHBUbHozbHNXQ1QxcEhn?oc=5","date":"2022-04-07","type":"trial","source":"PR Newswire UK","summary":"Vascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estimates DelveInsight - PR Newswire UK","headline":"Vascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBsaW1QNXVrSUQ0bDlqQWFtU0owTE1LelJrWHdaeklsamhjR2RWN2pvaUFxdE9kZHNuUWQtRzZFVXc1WXFNOTNQcjdHSm5rV1FyNC1VQ09jdm9YckR6bFdMb3FXblhaWk1xSWNORklkMGRUdm01LWtlTnFiS0JuOXM?oc=5","date":"2021-02-02","type":"trial","source":"Clinical Trials Arena","summary":"Pinteon reports positive data of trial for neurodegenerative tauopathy - Clinical Trials Arena","headline":"Pinteon reports positive data of trial for neurodegenerative tauopathy","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}